19 Results for "

BDK

" in MedChemExpress (MCE) Product Catalog:
Products (19)

19 Results for "BDK" in MCE Product Catalog:

9
9 Cited Publications
Cat. No.: HY-114855
CAS No.: 34576-94-8
Purity:  99.81%
Target:  

Bcl-2 Family

Research Areas:  

Metabolic Disease

BT2 is a BCKDC kinase (BDK) inhibitor with an IC50 of 3.19 μM. BT2 binding to BDK triggers helix movements in the N-terminal domain, resulting in the dissociation of BDK from the branched-chain α-ketoacid dehydrogenase complex (BCKDC) . BT2 (compound 4) is also a potent and selective Mcl-1 inhibitor with a Ki value of 59 μM .
loading...
    loading...
Cat. No.: HY-159648
CAS No.: 2936625-34-0
Target:  

Endogenous Metabolite

Research Areas:  

Cardiovascular Disease

PF-07328948 is an orally effective BDK (branch chain ketoacid dehydrogenase kinase) inhibitor, with IC50 of 110 nM. PF-07328948 acts as a BCKDH (branch chain ketoacid dehydrogenase) enzyme complex degrader to enhance BCAA (branch chain amino acid) catabolism. PF-07328948 improves metabolic and heart failure end points in rats .
loading...
    loading...
Cat. No.: HY-156193
CAS No.: 2573122-40-2
Purity:  99.69%
PF-07208254 is a selective, orally active allosteric inhibitor of branched-chain ketoacid dehydrogenase kinase (BDK) (IC50=110 nM, Ki=54 nM, KD=84 nM). PF-07208254 inhibits BDK-mediated BCKDH phosphorylation and enhances the catabolism of branched-chain amino acids (BCAAs) and branched-chain keto acids (BCKAs) by binding to the allosteric pocket of BDK, reducing BDK binding to BCKDH-E2 and promoting BDK degradation. PF-07208254 inhibits BDK activity in human skeletal muscle cells (IC50=540 nM) and has activity to improve cardiac function and metabolism. PF-07208254 can be used in the study of cardiometabolic diseases (e.g., heart failure, type 2 diabetes) .
loading...
    loading...
Cat. No.: HY-155157
Purity:  98.66%
PF-07247685 is a BCKDC kinase (BDK) inhibitor (EC50=2.2 nM). PF-07247685 stabilizes the interaction between BDK and BCKDH core subunit E2 and prevents phosphorylation of E1. While BDK mediates branched-chain ketoacid dehydrogenase (BCKDH) phosphorylation, and inhibition of BCKDH is involved in controlling the rate-limiting step of branched-chain amino acid (BCAA) degradation. Impaired BCAA catabolism has been associated with several diseases, particularly cardiometabolic diseases, including heart failure (HF), type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), and obesity. PF-07247685 improved cardiometabolic endpoints and improves glucose tolerance in mice .
loading...
    loading...
Cat. No.: HY-RS01411
Research Areas:  

Others

BCKDK Human Pre-designed siRNA Set A contains three designed siRNAs for BCKDK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-155156
Purity:  99.46%
PF-07238025 is a BCKDC kinase (BDK) inhibitor (EC50=19 nM). PF-07238025 stabilizes the interaction between BDK and BCKDH core subunit E2 and prevents phosphorylation of E1. While BDK mediates branched-chain ketoacid dehydrogenase (BCKDH) phosphorylation, and inhibition of BCKDH is involved in controlling the rate-limiting step of branched-chain amino acid (BCAA) degradation. Impaired BCAA catabolism has been associated with several diseases, particularly cardiometabolic diseases, including heart failure (HF), type 2 diabetes mellitus (T2DM), non-alcoholic fatty liver disease (NAFLD), and obesity. PF-07238025 improved cardiometabolic endpoints and improves glucose tolerance in mice .
loading...
    loading...
Cat. No.: HY-W110242
CAS No.: 41998-38-3
Target:  

PDHK

Research Areas:  

Metabolic Disease

(S)-CPP is an allosteric BDK inhibitor. (S)-CPP can be used in the research of type 2 diabetes .
loading...
    loading...
Cat. No.: HY-W110242A
CAS No.: 194979-70-9
Target:  

Endogenous Metabolite

Research Areas:  

Cardiovascular Disease

(S)-CPP sodium serves as an inhibitor of the branched-chain α-ketoacid dehydrogenase complex (BCKDC) kinase, commonly referred to as BDK or keto acid dehydrogenase kinase. As a negative regulator of BCKDC activity, the inhibition of BDK by (S)-CPP (with an IC50 of 6.3 μM) results in the activation of the complex and a notable decrease in plasma levels of leucine/isoleucine and valine in wild-type mice.
loading...
    loading...
Cat. No.: HY-RS19988
Research Areas:  

Others

Bckdk Mouse Pre-designed siRNA Set A contains three designed siRNAs for Bckdk gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS07411
Research Areas:  

Others

KNG1 Human Pre-designed siRNA Set A contains three designed siRNAs for KNG1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-169334
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

BDK-IN-1 (compound (-)-43) is a BDK inhibitor with the IC50 of 0.23 μM and the max inhibition of 90%. BDK-IN-1 decreases the level of phospho-E1 and can be used for study of cardiometabolic diseases .
loading...
    loading...
Cat. No.: HY-P73267
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Kininogen-1; HMWK; KNG1; BDK; KNG
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P73266
Purity:  ≥ 85%, as determined by reducing SDS-PAGE.
Synonyms: Kininogen-1; HMWK; KNG1; BDK; KNG
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P82992A
Synonyms: BDK; BCKDKD

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P82992
Synonyms: BDK; BCKDKD

Host:  

Rabbit

Application:  

WB

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-P70956
Purity:  ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: Kininogen-1; lpha-2-Thiol Proteinase Inhibitor; Fitzgerald Factor; High Molecular Weight Kininogen; HMWK; Williams-Fitzgerald-Flaujeac Factor; KNG1; BDK; KNG
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-RS26492
Research Areas:  

Others

Bckdk Rat Pre-designed siRNA Set A contains three designed siRNAs for Bckdk gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P82395
Synonyms: BDK; Bradykinin; HMWK; Kallidin I; Kallidin II; KNG; KNG1; WILLIAMS FACTOR

Host:  

Rabbit

Application:  

WB, IHC-P, IP

Reactivity:  

Human

loading...
    loading...
Cat. No.: HY-P810471
Synonyms: BCKDK, Branched Chain Keto Acid Dehydrogenase Kinase, [3-Methyl-2-Oxobutanoate Dehydrogenase [Lipoamide]] Kinase, Mitochondrial, Branched-Chain Alpha-Ketoacid Dehydrogenase Kinase, BCKDH Kinase, EC 2.7.11.4, BCKDHKIN, BDK, 3-Methyl-2-Oxobutanoate Dehydrogenase [Lipoamide] Kinase, Mitochondrial, Branched Chain Alpha-Ketoacid Dehydrogenase Kinase, Branched Chain Ketoacid Dehydrogenase Kinase, BCKD-Kinase, EC 2.7.11.1, EC 2.7.11, BCKDKD

Host:  

Rabbit

Application:  

WB, IHC-P

Reactivity:  

Human, mouse, rat

loading...
    loading...
  • 1